AGILE THERAPEUTICS INC (AGRX) Stock Analyst Earnings Estimates
NASDAQ:AGRX - Nasdaq - US00847L3087 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 750K | 4.1M 446.67% | 10.88M 165.37% | 20.448M 87.94% | 37.575M 83.76% | 51.95M 38.26% | 67.614M 30.15% | 112.1M 65.79% | 163.72M 46.05% | 143.76M -12.19% | 120.78M -15.98% | |
| EBITDA YoY % growth | -48.77M -160.80% | -68.79M -41.05% | -39.91M 41.98% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -49.05M -160.07% | -71.01M -44.77% | -41.44M 41.64% | -18.248M 55.97% | 2.642M 114.48% | 15.524M 487.59% | 29.734M 91.54% | 53.296M 79.24% | 99.719M 87.10% | 81.139M -18.63% | 60.074M -25.96% | |
| Operating Margin | -6,540.00% | -1,731.95% | -380.88% | -89.24% | 7.03% | 29.88% | 43.98% | 47.54% | 60.91% | 56.44% | 49.74% | |
| EPS YoY % growth | -24.00 -53.85% | -423.20 -1,663.33% | N/A 69.87% | -7.75 92.28% | 0.67 106.84% | 1.69 151.52% | 1.44 -15.06% | 2.58 79.43% | 10.32 300.00% | 8.08 -21.74% | 5.73 -29.04% |
All data in USD
| Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.52 91.20% | -0.32 85.29% | -0.10 62.22% | 0.02 101.35% |
| Revenue Q2Q % growth | 3.827M 0.45% | 5.741M 4.38% | 7.654M 14.92% | 8.611M 107.49% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.569M 46.81% | -2.157M 57.95% | -709.92K 82.25% | 123.42K 103.81% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -1.51 69.80% | -0.94 | -0.57 | -60.91% |
| Q3 2023 Q2Q % growth | -0.27 98.98% | -1.88 | 1.61 | 85.61% |
| Q2 2023 Q2Q % growth | -2.15 98.41% | -7.14 | 4.99 | 69.89% |
| Q1 2023 Q2Q % growth | -5.91 -56.35% | -7.65 | 1.74 | 22.75% |
| Q4 2022 Q2Q % growth | -5.00 98.75% | -11.73 | 6.73 | 57.37% |
| Q3 2022 Q2Q % growth | -26.50 -268.06% | -22.44 | -4.06 | -18.09% |
| Q2 2022 Q2Q % growth | -135.50 -1,593.75% | -188.70 | 53.20 | 28.19% |
| Q1 2022 Q2Q % growth | -3.78 52.75% | -4.90 | 1.12 | 22.79% |
| Q4 2021 Q2Q % growth | -400.00 -4,900.00% | -306.00 | -94.00 | -30.72% |
| Q3 2021 Q2Q % growth | -7.20 | -7.85 | 0.65 | 8.33% |
| Q2 2021 Q2Q % growth | -8.00 -66.67% | -8.81 | 0.81 | 9.22% |
| Q1 2021 Q2Q % growth | -8.00 -100.00% | -8.73 | 0.73 | 8.37% |
| Q4 2020 Q2Q % growth | -8.00 -100.00% | -9.14 | 1.14 | 12.46% |
| Q3 2020 Q2Q % growth | -7.20 -125.00% | -7.26 | 0.06 | 0.86% |
| Q2 2020 Q2Q % growth | -4.80 -50.00% | -5.71 | 0.91 | 15.97% |
| Q1 2020 Q2Q % growth | -4.00 23.08% | -3.59 | -0.41 | -11.41% |
| Q4 2019 Q2Q % growth | -4.00 | -3.06 | -0.94 | -30.72% |
| Q3 2019 Q2Q % growth | -3.20 | -3.33 | 0.13 | 3.97% |
| Q2 2019 Q2Q % growth | -3.20 | -4.62 | 1.42 | 30.79% |
| Q1 2019 Q2Q % growth | -5.20 | -4.32 | -0.88 | -20.24% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 3.75% | 4.15M | % | |
| Q3 2023 Q2Q % growth | 6.66M 122.00% | 6.904M | -244K | -3.53% |
| Q2 2023 Q2Q % growth | 5.5M 158.22% | 4.158M | 1.342M | 32.28% |
| Q1 2023 Q2Q % growth | 3.81M 116.48% | 3.465M | 345K | 9.96% |
| Q4 2022 Q2Q % growth | 4M 164.90% | 3.147M | 853K | 27.11% |
| Q3 2022 Q2Q % growth | 3M 132.56% | 2.38M | 620K | 26.05% |
| Q2 2022 Q2Q % growth | 2.13M 78.99% | 2.021M | 109K | 5.39% |
| Q1 2022 Q2Q % growth | 1.76M 1,366.67% | 1.491M | 269K | 18.04% |
| Q4 2021 Q2Q % growth | 1.51M 101.33% | 1.542M | -32K | -2.08% |
| Q3 2021 Q2Q % growth | 1.29M | 1.491M | -201K | -13.48% |
| Q2 2021 Q2Q % growth | 1.19M | 1.156M | 34K | 2.94% |
| Q1 2021 Q2Q % growth | 120K | 264.384K | -144.384K | -54.61% |
| Q4 2020 Q2Q % growth | 750K | 1.027M | -277K | -26.97% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -70.37% | -70.37% | 0% | 0% |
| Revenue | -55.77% | -55.77% | -20.71% | -20.71% |